← Sites
709 (USA)
USA
PI: Dr. Novak
activated
KRI 0.01
Patients
23
Active (enrolled/consented)
0
Withdrawn
1
Serious AEs
1
Open QA findings
0
Aged data queries
0
Studies & contracts total budget 263500.00 USD
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
study completed
contract executed
263500 USD
Patients first 23
| Ref | Status | Consented | Study |
|---|---|---|---|
| 709-1001 | completed | 2013-10-08 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1007 | completed | 2012-07-31 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1020 | completed | 2012-12-01 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1029 | completed | 2012-12-25 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1081 | completed | 2014-01-18 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1088 | completed | 2014-04-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1099 | completed | 2013-10-25 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1102 | completed | 2013-01-15 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1168 | completed | 2013-08-02 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1217 | completed | 2013-03-04 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1224 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 709-1237 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 709-1238 | completed | 2013-05-15 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1259 | completed | 2013-01-26 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1285 | completed | 2013-03-24 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1301 | completed | 2013-07-19 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1306 | completed | 2014-02-03 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1309 | completed | 2013-06-19 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1312 | completed | 2014-04-20 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1326 | completed | 2013-04-05 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1329 | withdrawn | 2013-08-15 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1339 | completed | 2012-12-23 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 709-1424 | completed | 2013-03-03 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
Luna participants (0)
No participants at this site use Luna yet.
Safety 122 AEs · 1 serious
serious
709-1424
reported
Moderate SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-03-07 (study day 5.0); relationship: POSSIBLE; serious criteria: life-threatening
QA findings 0 open
No findings recorded.
Monitoring visits (0)
No visits recorded.
Payments (0)
No payments on file.